Learn / CATX
NYSE: CATX
Perspective Therapeutics (CATX) stock, explained like you're 5
Perspective Therapeutics trades on the New York Stock Exchange under the ticker CATX. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 304 million dollars.
- Ticker
- CATX
- Exchange
- New York Stock Exchange
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Small cap, about 304 million dollars
Is Perspective Therapeutics a small, medium or large cap company?
No. Perspective Therapeutics is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 304 million dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Perspective Therapeutics makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves CATX stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Perspective Therapeutics, Inc. (CATX) Stock Price, News, Quote & History (Yahoo! Finance Canada)
- $CATX stock is down 9% today. Here's what we see in our data. (Quiver Quantitative)
- Perspective Therapeutics (CATX) Institutional Ownership 2026 (MarketBeat)
- After selling nearly 1.4 million shares in one day, a Perspective Therapeutics (CATX) holder still has a stake. (Stock Titan)
- Perspective Therapeutics (CATX) Receives a Buy from Wedbush (The Globe and Mail)
Follow CATX in your daily brief
Each trading day at 5 PM ET we post what happened to Perspective Therapeutics and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow CATX
Questions about Perspective Therapeutics stock
What does Perspective Therapeutics do?
Perspective Therapeutics trades on the New York Stock Exchange under the ticker CATX. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 304 million dollars.
What is the ticker symbol for Perspective Therapeutics?
Perspective Therapeutics trades under the ticker CATX on the New York Stock Exchange.
What is Perspective Therapeutics's market cap?
Perspective Therapeutics is a small cap stock with a market cap of about 304 million dollars.
How does Perspective Therapeutics make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves CATX stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow CATX stock every day?
Add CATX to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.